世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032180

アプタマー市場-2022-2030予測

Grand View Research Inc.

Aptamers Market Size, Share & Trends Analysis Report By Type (Nucleic Acid, Peptide), By Application (Diagnostics, Therapeutics, Research & Developments), By Region, And Segment Forecasts, 2022 - 2030

発刊日 2022/05

言語英語

体裁PDF/89ページ

ライセンス/価格89ページ

0000032180

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

アプタマーの市場規模、シェアおよび動向分析レポート:種類別(核酸、ペプチド)、用途別(診断、治療、研究開発)、地域別、およびセグメント予測、2022〜2030

レポートの概要
世界のアプタマーの市場の規模は2021年に16億2450万ドルと評価され、2022年から2030年までは23.5%のCAGRで拡大すると予想されます。標的細胞を殺すための生成、精製、およびドラッグデリバリーにおける最近の進歩は、それらに関連する競争上の利点によって、多くの研究者からアプタマーに対する注目が集まっています。分子サイズが小さい、免疫原性が低い、製造コストが低い、抗体と比較して副作用が少ないなどのいくつかの利点によって、新規アプタマーの研究開発が促進され、それによって市場の成長を促進する可能性があります。

レポート詳細

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation and Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Aptamers Market Variables, Trends, and Scope
3.1 Market Variable Analysis
3.2 Penetration and Growth Prospect Mapping
3.3 Driver Impact Analysis
3.3.1 High advantage of aptamers compared to antibodies
3.3.2 Advancements in the field of aptamer development technologies
3.3.3 Growing interest of many companies to invest in aptamers market
3.3.4 Promising pipeline thearpeutics
3.4 Market Restraint Analysis
3.4.1 Rising number of setbacks of aptamer therapeutics in late stage clinical studies
3.4.2 Low awareness level and incomplete regulatory policies slow down the market growth
3.5 SWOT Analysis; By factor (Political & Legal, Economic and Technological)
3.6 Porter’s Five Forces Analysis
3.7 Regulatory Framework

Chapter 4 Aptamers Market: Segment Analysis, by Type, 2018 - 2030 (USD Million)
4.1 Aptamers Market: Type Movement Analysis
4.2 Nucleic Acid
4.2.1 Nucleic Acid market estimates and forecast, 2018-2030
4.3 Peptide
4.3.1 Peptide market estimates and forecast, 2018-2030

Chapter 5 Aptamers Market: Segment Analysis, by Application, 2018 - 2030 (USD Million)
5.1 Aptamers Market: Application Movement Analysis
5.2 Diagnostics
5.2.1 Diagnostics market estimates and forecast, 2018-2030
5.3 Therapeutics
5.3.1 Therapeutics market estimates and forecast, 2018-2030
5.4 Research and development
5.4.1 Research and development market estimates and forecast, 2018-2030
5.5 Others
5.5.1 Others market estimates and forecast, 2018-2030

Chapter 6 Aptamers Market: Segment Analysis, by Region, 2018 - 2030 (USD Million)
6.1 Regional Market Share Analysis, 2021 & 2030
6.2 Regional Market Snapshot
6.3 Market Size, Forecasts, and Revenue & Trend Analysis, 2021 to 2030
6.3.1 North America
6.3.1.1 North America Aptamers market estimates and forecast, 2018 - 2030 (USD Million)
6.3.1.2 U.S.
6.3.1.2.1 U.S. Aptamers market, 2018 - 2030 (USD Million)
6.3.1.3 Canada
6.3.1.3.1 Canada Aptamers market, 2018 - 2030 (USD Million)
6.3.1.4 Mexico
6.3.1.4.1 Mexico Aptamers market, 2018 - 2030 (USD Million)
6.3.2 Europe
6.3.2.1 Europe Aptamers market, 2018 - 2030 (USD Million)
6.3.2.2 U.K.
6.3.2.2.1 U.K. Aptamers market, 2018 - 2030 (USD Million)
6.3.2.3 Germany
6.3.2.3.1 Germany Aptamers market, 2018 - 2030 (USD Million)
6.3.2.4 Spain
6.3.2.4.1 Spain Aptamers market, 2018 - 2030 (USD Million)
6.3.2.5 France
6.3.2.5.1 France Aptamers market, 2018 - 2030 (USD Million)
6.3.2.6 Italy
6.3.2.6.1 Italy Aptamers market, 2018 - 2030 (USD Million)
6.3.3 Asia Pacific
6.3.3.1 Asia Pacific Aptamers market, 2018 - 2030 (USD Million)
6.3.3.2 Japan
6.3.3.2.1 Japan Aptamers market, 2018 - 2030 (USD Million)
6.3.3.3 China
6.3.3.3.1 China Aptamers market, 2018 - 2030 (USD Million)
6.3.3.4 India
6.3.3.4.1 India Aptamers market, 2018 - 2030 (USD Million)
6.3.3.5 Australia
6.3.3.5.1 Australia Aptamers market, 2018 - 2030 (USD Million)
6.3.3.6 South Korea
6.3.3.6.1 South Korea Aptamers market, 2018 - 2030 (USD Million)
6.3.4 Latin America
6.3.4.1 Latin America Aptamers market, 2018 - 2030 (USD Million)
6.3.4.2 Brazil
6.3.4.2.1 Brazil Aptamers market, 2018 - 2030 (USD Million)
6.3.4.3 Mexico
6.3.4.3.1 Mexico Aptamers market, 2018 - 2030 (USD Million)
6.3.4.4 Argentina
6.3.4.4.1 Argentina Aptamers market, 2018 - 2030 (USD Million)
6.3.5 MEA
6.3.5.1 MEA Aptamers market, 2018 - 2030 (USD Million)
6.3.5.2 South Africa
6.3.5.2.1 South Africa Aptamers market, 2018 - 2030 (USD Million)
6.3.5.3 Saudi Arabia
6.3.5.3.1 Saudi Arabia Aptamers market, 2018 - 2030 (USD Million)
6.3.5.4 UAE
6.3.5.4.1 UAE Aptamers market, 2018 - 2030 (USD Million)

Chapter 7 Aptamers Market: Competitive Analysis
7.1 Major deals & strategic alliances analysis
7.1.1 New product launch
7.1.2 Mergers and acquisitions
7.1.3 Expansion
7.1.4 Partnerships
7.2 Vendor Landscape
7.2.1 List of key distributors and channel partners
7.3 Public Companies
7.3.1 Company market position analysis
7.3.2 Competitive Dashboard Analysis
7.4 Private Companies
7.4.1 List of key emerging companies/Technology disruptors/ innovators

Chapter 8 COMPANY PROFILES
8.1 SomaLogic
8.1.1 Company overview
8.1.2 Financial Performance
8.1.3 Product benchmarking
8.1.4 Strategic initiatives
8.2 Aptamer Group
8.2.1 Company overview
8.2.2 Financial Performance
8.2.3 Product benchmarking
8.2.4 Strategic initiatives
8.3 Aptamer Sciences, Inc.
8.3.1 Company overview
8.3.2 Financial performance
8.3.3 Product benchmarking
8.3.4 Strategic initiatives
8.4 Base Pair Biotechnologies
8.4.1 Company overview
8.4.2 Financial performance
8.4.3 Product benchmarking
8.4.4 Strategic initiatives
8.5 Noxxon Pharma
8.5.1 Company overview
8.5.2 Financial Performance
8.5.3 Product benchmarking
8.5.4 Strategic initiatives
8.6 Vivonics, Inc.
8.6.1 Company overview
8.6.2 Financial Performance
8.6.3 Product benchmarking
8.6.4 Strategic initiatives
8.7 Aptagen, LLC
8.7.1 Company overview
8.7.2 Financial Performance
8.7.3 Product benchmarking
8.7.4 Strategic initiatives
8.8 TriLink BioTechnologies
8.8.1 Company overview
8.8.2 Financial Performance
8.8.3 Product benchmarking
8.8.4 Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Key Difference between Antibody and Aptamers
Table 4 Key aptamers in different stages
Table 5 Regulatory framework
Table 6 List of key distributors
Table 7 List of key emerging companies/technology disruptors/innovators
Table 8 North America aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 9 North America aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 10 U.S. aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 11 U.S. aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 12 Canada aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 13 Canada aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 14 Europe aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 15 Europe aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 16 U.K. aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 17 U.K. aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 18 Germany aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 19 Germany aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 20 France aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 21 France aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 22 Italy aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 23 Italy aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 24 Spain aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 25 Spain aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 26 Asia Pacific aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 27 Asia Pacific aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 28 Japan aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 29 Japan aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 30 China aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 31 China aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 32 India aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 33 India aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 34 Australia aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 35 Australia aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 36 South Korea aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 37 South Korea aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 38 Latin America aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 39 Latin America aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 40 Brazil aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 41 Brazil aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 42 Mexico aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 43 Mexico aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 44 Argentina aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 45 Argentina aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 46 MEA aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 47 MEA aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 48 South Africa aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 49 South Africa aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 50 Saudi Arabia aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 52 UAE aptamers market estimates and forecasts, by type, 2018 - 2030 (USD Million)
Table 53 UAE aptamers market estimates and forecasts, by application, 2018 - 2030 (USD Million)
Table 54 List of key distributors
Table 55 List of key emerging companies/technology disruptors/innovators

List of Figures
Fig. 1 Aptamers market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Commodity flow approach
Fig. 10 Market outlook (2021) (USD million)
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Aptamers market driver impact
Fig. 13 Aptamers market restraint impact
Fig. 14 SWOT analysis, by factor (political & legal economic and technological)
Fig. 15 Porter’s five forces analysis
Fig. 16 Aptamers by type outlook: Key takeaways
Fig. 17 Aptamers market: Type movement analysis
Fig. 18 Nucleic acid market estimates and forecasts, 2018 - 2030
Fig. 19 Peptide market estimates and forecasts, 2018 - 2030
Fig. 20 Aptamers by application outlook: Key takeaways
Fig. 21 Aptamers market: Application movement analysis
Fig. 22 Diagnostics market estimates and forecasts, 2018 - 2030
Fig. 23 Therapeutics market estimates and forecasts, 2018 - 2030
Fig. 24 Research and development market estimates and forecasts, 2018 - 2030
Fig. 25 Others market estimates and forecasts, 2018 - 2030
Fig. 26 Regional outlook, 2021 & 2030
Fig. 27 Regional marketplace: Key takeaways
Fig. 28 North America
Fig. 29 North America aptamers market, 2018 - 2030 (USD million)
Fig. 30 U.S.
Fig. 31 U.S. aptamers market, 2018 - 2030 (USD million)
Fig. 32 Canada
Fig. 33 Canada aptamers market, 2018 - 2030 (USD million)
Fig. 34 Europe
Fig. 35 Europe aptamers market, 2018 - 2030 (USD million)
Fig. 36 U.K.
Fig. 37 U.K. aptamers market, 2018 - 2030 (USD million)
Fig. 38 Germany
Fig. 39 Germany aptamers market, 2018 - 2030 (USD million)
Fig. 40 Spain
Fig. 41 Spain aptamers market, 2018 - 2030 (USD million)
Fig. 42 France
Fig. 43 France aptamers market, 2018 - 2030 (USD million)
Fig. 44 Italy
Fig. 45 Italy aptamers market, 2018 - 2030 (USD million)
Fig. 46 Asia Pacific
Fig. 47 Asia Pacific aptamers market, 2018 - 2030 (USD million)
Fig. 48 Japan
Fig. 49 Japan aptamers market, 2018 - 2030 (USD million)
Fig. 50 China
Fig. 51 China aptamers market, 2018 - 2030 (USD million)
Fig. 52 India
Fig. 53 India aptamers market, 2018 - 2030 (USD million)
Fig. 54 Australia
Fig. 55 Australia aptamers market, 2018 - 2030 (USD million)
Fig. 56 South Korea
Fig. 57 South Korea aptamers market, 2018 - 2030 (USD million)
Fig. 58 Latin America
Fig. 59 Latin America aptamers market, 2018 - 2030 (USD million)
Fig. 60 Brazil
Fig. 61 Brazil aptamers market, 2018 - 2030 (USD million)
Fig. 62 Mexico
Fig. 63 Mexico aptamers market, 2018 - 2030 (USD million)
Fig. 64 Argentina
Fig. 65 Argentina aptamers market, 2018 - 2030 (USD million)
Fig. 66 Middle East & Africa
Fig. 67 MEA aptamers market, 2018 - 2030 (USD million)
Fig. 68 South Africa
Fig. 69 South Africa aptamers market, 2018 - 2030 (USD million)
Fig. 70 Saudi Arabia
Fig. 71 Saudi Arabia aptamers market, 2018 - 2030 (USD million)
Fig. 72 UAE
Fig. 73 UAE aptamers market, 2018 - 2030 (USD million)
Fig. 74 Company market position analysis (Revenue US$ mn)
Fig. 75 Company market position analysis (Profit Margin)
Fig. 76 Competitive dashboard analysis
Fig. 77 Regional Network Map

この商品のレポートナンバー

0000032180

TOP